Could space be the key to better, faster drug development?In this episode of In-Orbit, host Dallas Campbell explores how microgravity environments are reshaping the future of pharmaceuticals. With guests Dr Martin Braddock from GENIXICONSULTING and William Birch from the Satellite Applications Catapult, the discussion dives into why the absence of gravity enables better crystal growth, enhances drug discovery, and opens new possibilities for biomanufacturing in space. The episode unpacks both the science and commercial potential of conducting pharmaceutical R&D off-planet, from creating more effective drugs to future ambitions like 3D bioprinting human tissue in orbit.The conversation doesn’t shy away from the challenges — including cost, regulatory barriers, and the need for new infrastructure. Whether you're a pharmaceutical innovator, space enthusiast, or curious about the intersection of health and space, this episode offers a fascinating glimpse into how drug development could be transformed in the next decade.<ul><li>(00:00) - Welcome to In-Orbit</li>
<li>(00:33) - Meet the Experts: Martin and William</li>
<li>(03:29) - Understanding Microgravity</li>
<li>(06:26) - Microgravity's Impact on the Human Body</li>
<li>(08:47) - Crystals and Drug Design in Space</li>
<li>(16:16) - The Future of Pharmaceuticals in Space</li>
<li>(17:41) - Introduction to Space Drug Development</li>
<li>(17:52) - Experiments and Companies in Space</li>
<li>(20:03) - Challenges and Regulatory Hurdles</li>
<li>(21:35) - Bone Loss and Osteoporosis Drugs</li>
<li>(28:50) - 3D Bioprinting and Future Prospects</li>
<li>(32:27) - Investment and Future of Space Medicine</li>
</ul>Dr Martin Braddock: Founder and Director of GENIXICONSULTING, with over 29 years in biopharma including roles at AstraZeneca and GlaxoSmithKline. He is a leading advocate for integrating microgravity into drug development.William Birch: Strategic Account Director for Space at the Satellite Applications Catapult, where he connects industry players to drive R&D and economic growth in the UK space sector. Formerly worked in biomedical corporate finance with a focus on longevity research.Satellite Applications Catapult: <a href="https://www.linkedin.com/company/satellite-applications-catapult">LinkedIn</a>, <a href="https://twitter.com/SatAppsCatapult">Twitter/X</a>, <a href="https://www.facebook.com/SatAppsCatapult">Facebook</a>, <a href="https://sa.catapult.org.uk/">Website</a>
<a href="https://www.storyninetyfour.com/">Produced by Story Ninety-Four in Oxford.</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Microgravity: Developing Drugs in Space

In-Orbit

AI Chapters

AI Insights

Reviews